Federal investigators say that a Chinese drug manufacturer, previously on the Food and Drug Administration’s list of preapproved foreign companies allowed to import GLP-1 ingredients, was able to ...
GLP-1 receptor agonist weight loss drugs suppress appetite for food but may also reduce mood and desire for sex in some ...
For the first time, Medicare will cover GLP-1 drugs prescribed solely for weight loss for eligible beneficiaries at a $50 ...
The “fauxzempic” era is well underway. Many brands are marketing alternatives to GLP-1 weight-loss drugs, but certain foods ...
In contrast, one research trial using GLP-1 drugs on obese research subjects did not show a benefit from GLP-1 in the ...
MedPage Today on MSN
Study Compares GLP-1 Drugs on Their Benefits, Harms
Quality-of-life effects still a major unknown, researchers say ...
Eli Lilly makes the best-selling GLP-1 drug, and sales are accelerating.
A network meta-analysis of nine randomized controlled trials found that once-weekly semaglutide showed the largest estimated ...
A target trial emulation found that people with type 2 diabetes who started glucagon-like peptide-1 receptor agonist (GLP-1RA ...
GLP-1 weight loss drugs just got a lot cheaper for many older Americans. Starting Wednesday, the federal government is ...
Ozempic and other GLP-1s could have a surprising effect on the progression of cancer.
The percentage of American adults who are currently taking a GLP-1 drug for weight loss is 11%, according to a new survey ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results